| Financial Year |
March 31 2023 |
| Monetary Funds |
46,674,694.00 |
| Held-for-trading Financial Assets |
1,100,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
315,861,630.20 |
| Advances to Suppliers |
141,460.00 |
| Other Receivables |
1,588,270.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
365,840,164.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
323,635,192.44 |
| Investment Properties |
-- |
| Fixed Assetes |
360,480,695.43 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,924,163.09 |
| R&D expenses |
-- |
| Goodwill |
718,214.87 |
| Long-Term Deferred and Prepaid Expenses |
10,887,000.00 |
| Deferred Income Tax Assets |
3,189,540.33 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
704,219,097.50 |
| Total Assets |
1,070,059,261.75 |
| Short-Term Loans |
25,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,111,944.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
62,679.70 |
| Taxes Payable |
7,214,849.07 |
| Interest Payable |
-- |
| Dividend Payable |
3,568,649.00 |
| Other payables |
4,609,158.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
72,238,676.78 |
| Other Current Liabilities |
2,050,000.00 |
| Sub-Total of Current Liabilities |
112,287,309.15 |
| Long-term Loans |
376,800,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,326,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
382,126,000.00 |
| Total Liabilities |
494,413,309.15 |
| Paid-In Capital(Or Share Stock) |
349,000,000.00 |
| Capital Surplus |
194,547,992.05 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
31,243,194.98 |
| Minority Stockholder's Interest |
854,765.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
574,791,187.03 |
| Owner's Equity（Stockholder's Equity） |
575,645,952.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,070,059,261.75 |
